| Comparison of three magnetic resonance enterography indices for grading activity in Crohn’s disease J Rimola, A Alvarez-Cofiño, T Pérez-Jeldres, C Ayuso, I Alfaro, ... Journal of gastroenterology 52, 585-593, 2017 | 114 | 2017 |
| Targeting cytokine signaling and lymphocyte traffic via small molecules in inflammatory bowel disease: JAK inhibitors and S1PR agonists T Pérez-Jeldres, CJ Tyler, JD Boyer, T Karuppuchamy, A Yarur, DA Giles, ... Frontiers in pharmacology 10, 212, 2019 | 113 | 2019 |
| Targeting sphingosine-1-phosphate signaling in immune-mediated diseases: beyond multiple sclerosis T Pérez-Jeldres, M Alvarez-Lobos, J Rivera-Nieves Drugs 81 (9), 985-1002, 2021 | 101 | 2021 |
| Incidence, clinical characteristics, and management of psoriasis induced by anti-TNF therapy in patients with inflammatory bowel disease: a nationwide cohort study I Guerra, T Pérez-Jeldres, M Iborra, A Algaba, D Monfort, X Calvet, ... Inflammatory bowel diseases 22 (4), 894-901, 2016 | 90 | 2016 |
| Cell trafficking interference in inflammatory bowel disease: therapeutic interventions based on basic pathogenesis concepts T Pérez-Jeldres, CJ Tyler, JD Boyer, T Karuppuchamy, G Bamias, ... Inflammatory bowel diseases 25 (2), 270-282, 2019 | 54 | 2019 |
| Sphingosine-1-phosphate lyase inhibition alters the S1P gradient and ameliorates Crohn’s-like ileitis by suppressing thymocyte maturation T Karuppuchamy, CJ Tyler, LR Lundborg, T Pérez-Jeldres, AK Kimball, ... Inflammatory Bowel Diseases 26 (2), 216-228, 2020 | 25 | 2020 |
| Increasing efficiency of MRE for diagnosis of Crohn’s disease activity through proper sequence selection: a practical approach for clinical trials J Rimola, A Alvarez-Cofiño, T Pérez-Jeldres, S Rodríguez, I Alfaro, ... Abdominal Radiology 42, 2783-2791, 2017 | 24 | 2017 |
| Spanish GETECCU group (ENEIDA project). Incidence, clinical characteristics, and management of psoriasis induced by anti-TNF therapy in patients with inflammatory bowel disease … I Guerra, T Pérez-Jeldres, M Iborra, A Algaba, D Monfort, X Calvet, ... Inflamm Bowel Dis 22 (4), 894-901, 2016 | 13 | 2016 |
| Metabolic activation and colitis pathogenesis is prevented by lymphotoxin β receptor expression in neutrophils T Riffelmacher, DA Giles, S Zahner, M Dicker, AY Andreyev, S McArdle, ... Mucosal immunology 14 (3), 679-690, 2021 | 11 | 2021 |
| Inherent immune cell variation within colonic segments presents challenges for clinical trial design CJ Tyler, M Guzman, LR Lundborg, S Yeasmin, T Perez-Jeldres, A Yarur, ... Journal of Crohn's and Colitis 14 (10), 1364-1377, 2020 | 8 | 2020 |
| Implementation of mass cytometry as a tool for mechanism of action studies in inflammatory bowel disease CJ Tyler, T Pérez-Jeldres, E Ehinger, B Capaldo, T Karuppuchamy, ... Inflammatory bowel diseases 24 (11), 2366-2376, 2018 | 7 | 2018 |
| Targeting cytokine signaling and lymphocyte traffic via small molecules in inflammatory bowel disease: JAK inhibitors and S1PR agonists. Front Pharmacol. 2019; 10 (212): 1-15 T Pérez-Jeldres, CJ Tyler, JD Boyer, T Karuppuchamy, A Yarur, DA Giles | 6 | 2019 |
| Modulation of the Acute Inflammatory Response Induced by the Escherichia coli Lipopolysaccharide through the Interaction of Pentoxifylline and Florfenicol in a … V Cazanga, C Palma, T Casanova, D Rojas, K Barrera, C Valenzuela, ... Antibiotics 12 (4), 639, 2023 | 3 | 2023 |
| The cell circuitry of ulcerative colitis, a new view for a highly complex disease T Perez-Jeldres, M Alvarez-Lobos, JR Nieves, EJ Villablanca Gastroenterology 158 (5), 1506-1508, 2020 | 3 | 2020 |
| CD4+-mediated colitis in mice is independent of the GPR183 and GPR18 pathways M Dicker, Y Li, DA Giles, G Verstichel, VC Castelan, G Ascui-Gac, ... Frontiers in Immunology 13, 1034648, 2022 | 2 | 2022 |
| Ethnicity influences phenotype and clinical outcomes: Comparing a South American with a North American inflammatory bowel disease cohort T Pérez-Jeldres, B Pizarro, G Ascui, M Orellana, M Cerda-Villablanca, ... Medicine 101 (36), e30216, 2022 | 1 | 2022 |
| Correction to: Targeting Sphingosine-1-Phosphate Signaling in Immune-Mediated Diseases: Beyond Multiple Sclerosis T Pérez-Jeldres, M Alvarez-Lobos, J Rivera-Nieves Drugs 81 (12), 1451, 2021 | 1 | 2021 |
| Genotype Prevalence of Lactose Deficiency, Vitamin D Deficiency, and the Vitamin D Receptor in a Chilean Inflammatory Bowel Disease Cohort: Insights from an Observational Study T Pérez-Jeldres, ML Bustamante, R Segovia-Melero, N Aguilar, F Magne, ... International Journal of Molecular Sciences 24 (19), 14866, 2023 | | 2023 |
| Amerindian ancestry proportion as a risk factor for inflammatory bowel diseases: results from a Latin American Andean cohort T Pérez-Jeldres, F Magne, G Ascui, D Alvares, M Orellana, ... Frontiers in Medicine 10, 2023 | | 2023 |
| Telemedicine: Maintaining The Control and Clinical Outcomes During COVID-19 Pandemic in an IBD South American Unit with Patient Centered Care T Pérez-Jeldres Clinics of Surgery 4 (3), 1-9, 2020 | | 2020 |
